Chu L, Tan D, Zhu M, Qu Y, et al. EZH2 W113C is a gain-of-function mutation in B cell lymphoma enabling both PRC2 methyltransferase activation and tazemetostat resistance. J Biol Chem 2023 Feb 27:103073. doi: 10.1016/j.jbc.2023.103073.
PMID: 36858198